Turning Killers into THINKers: TME Hostility-Impervious NK Cells for Treating Neuroblastoma and Sarcoma |
Baylor College of Medicine / Robin Parihar, MD/PhD |
'A' Award Grants |
2021 |
Texas |
Identifying Rare Genetic Variants Involved in High Risk Pediatric Leukemia Via Pooled Sequencing |
Washington University / Todd Druley, MD, PhD |
'A' Award Grants |
2009 |
Missouri |
Uncovering the signaling mechanisms allowing medulloblastoma progenitor cells to orchestrate tumor relapse |
Medical University of South Carolina / Jezabel Rodriguez Blanco, PhD |
'A' Award Grants |
2023 |
South Carolina |
Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma |
The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD |
'A' Award Grants |
2019 |
California |
Inside-Out Immunotherapy: Combating Neuroblastoma via Nanoparticle-Directed Reprogramming of the Tumor Microenvironment |
Vanderbilt University Medical Center / John Wilson, PhD |
'A' Award Grants |
2015 |
Tennessee |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
The Role of the Innate Immune System in Immune Dysregulation following CART |
Children’s Hospital of Philadelphia / Caroline Diorio, MD |
'A' Award Grants |
2023 |
Pennsylvania |
A Role for Notch in Self-renewal in Embryonal Rhabdomyosarcoma |
Massachusetts General Hospital / Myron Ignatius, PhD |
'A' Award Grants |
2012 |
Massachusetts |
Characterizing the Developmental Context of Pediatric Leukemia
|
Icahn School of Medicine at Mount Sinai / Elvin Wagenblast, PhD |
'A' Award Grants |
2022 |
New York |
IDO-based Immunotherapy for Pediatric Brain Tumors
|
Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, MD, PhD |
'A' Award Grants |
2013 |
Georgia |